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One of the most rewarding things about a career in health care is seeing the progress we make in treating illness
and disease. While the so-called “war on cancer” continues, we know we have many new weapons to help the
children who are fighting this struggle.
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Yet, as we are more successful in fighting and defeating the scourge of cancer, we must confront new challenges:
how do we help the survivors and their families deal with the unique problems they are presented with? That’s
where our special Survive & Thrive program comes in. It is the focus of this 2014 Cancer Care Annual Report.
Survive & Thrive is designed for the special needs of cancer survivors, and their numbers are thankfully growing!
Working with the Midwest Cancer Alliance and the University of Kansas, we help our patients transition their care
from Children’s Mercy to an adult health-care setting. While transitioning can be difficult, we smooth the path to
make it less so.
Please take a few moments to look at what we have accomplished. Take note of 14-year old Emily who, along
with her family, received devastating news in 2002 that she had brain cancer. Two surgeries and rounds and
rounds of chemotherapy later, Emily has now been cancer free for 10 years and is as gregarious and lively as
ever. She is part of Survive & Thrive.

Randall L. O’Donnell, PhD
President and CEO
Children’s Mercy

Emily is also the reason we are all here. To make progress. To win the battles. To fight for the children – who are
our real bosses!
Sincerely,
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In this year’s annual report of the Children’s Mercy Cancer Center, we focus on our patients’ long-term outcomes
and their quality of life after cancer.
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Alan S. Gamis, MD, MPH
Associate Division Director,
Division of Hematology/
Oncology/BMT
Chief, Section of Oncology
Professor of Pediatrics,
University of MissouriKansas City School of
Medicine

Among the variety of programs here, I am pleased to introduce to you our established and expanding Survive
& Thrive program. As you will see, this is a comprehensive effort of many health care professionals and medical
specialties. As both a clinical service to our current patients and a research program to benefit our future
patients, we are committed to reduce sequelae of cancer and its therapy, to overcome those sequelae that do
occur, and to assist our children in their transition to adult providers who are up to date on the experiences and
the challenges faced by our survivors.
I hope this year’s annual report will provide you a better understanding of the challenges these children face and
the wonderful program we have to help our patients thrive after their battle with cancer.

Dear Colleagues and Friends,
In the past, our annual report has focused on certain types of cancer.
This year, it is my pleasure to be able to present a topic – survivorship -- that pertains to all of our patients.
Almost 80 percent of children diagnosed with cancer survive! With this increase in survival rates, we have been able to
devote more time and effort to learning about issues affecting cancer survivors and improving their quality of life.
The diagnosis and treatment of cancer disrupts a person’s normal growth and development. Our goal at Children’s Mercy is
to provide treatment that minimizes this disruption. We do this with a multidisciplinary approach.
Joy M. Fulbright, MD
Director, Survive & Thrive
Program
Director, Adolescent and
Young Adult Program
Division of Hematology/
Oncology/BMT
Assistant Professor of
Pediatrics, University of
Missouri-Kansas City School
of Medicine

Starting from the time of diagnosis, patients and families meet with a social worker and a nurse practitioner. Emotional
and physical support is provided throughout therapy by child life, chaplaincy, psychology, music therapy, physical therapy
and occupational therapy. We are able to provide massage therapy and a full-time school teacher thanks to generous
community support. I tell my patients that we want them to get smarter during therapy!
We are fortunate to have the resources to continue this multidisciplinary care after patients complete their cancer therapy.
Patients who completed therapy at least two years ago and it has been five years since they were diagnosed are followed in
the Survive & Thrive Program. The name of the clinic reminds us of its mission, which is to ensure that after survival of cancer,
patients thrive and are provided with the tools they need to lead healthy and meaningful lives.
Over the last couple of decades, we have been working toward making cancer therapy less toxic. Unfortunately, many of
the more effective cancer therapies can still cause immediate and long-term side effects. This annual report focuses on the
services and education we provide for our patients and their families to help identify, prevent and treat late effects.
There are many transitions in a cancer patient’s journey: diagnosis and treatment, completion of treatment, transition from
the primary oncologist to the Survive & Thrive Program, and finally, leaving Children’s Mercy to move into care with an adult
provider. One of the main goals in Survive & Thrive is to help facilitate the transition to adult care. We provide resources,
facilitate conversations and work with community providers to ensure that this last transition is as smooth as possible.
I hope by reading this year’s report you will learn from our survivors the amazing things they are doing with their lives and
about the work that goes on at Children’s Mercy to help them on their journey.
Thank you for trusting us with the care of these remarkable patients who are your friends,
neighbors, patients, and relatives. I feel blessed every day to provide care for them and to work in an
organization and community that cares so much.
All the Best,
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CANCER
REGISTRY

The Cancer Registry at Children’s Mercy is a database of all cancer
and benign brain tumor patients that are diagnosed or treated
here. All heath care facilities are required by federal and state
law to report basic information about cancer and benign brain
tumors. Without complete and accurate data, it would be difficult
to develop effective, comprehensive cancer prevention and control
programs.

2013 Registry Facts and Figures
•

174 new primary diseases added. (See the frequency table for
further breakdown of disease types and percentages.)

•

The median age of diagnosis was 9.5 years old.

As we look at survival in this annual report, we are reminded of
the need for follow-up with our patients so we can evaluate the
best treatment methods and know the outcomes.
The registry staff at Children’s Mercy keeps disease status and
follow-up information current. This is done by contacting primary
care physicians, accessing the patient’s Children’s Mercy medical
record, and directly contacting the parents and patients. All of the
registry activities are conducted according to the HIPAA privacy
regulations. Please feel free to contact the registry by secure email
at cancerregistry@cmh.edu.
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•

23 patients were less than 1 year of age when diagnosed

•

48 patients ages 1-4

•

33 patients ages 5-9

•

40 patients ages 10-14

•

30 patients ages 15-19.

•

88 females and 86 males

•

148 Caucasians (including 21 identified as of Spanish/Hispanic
ethnicity)

•

19 African-Americans

•

7 designated as “other” race.

Five-Year Relative Survival-National Comparison
Patients Diagnosed from 2004 to 2010
Children’s Mercy Kansas City Versus Surveillance
Epidemiology and End Results (SEER)
DIAGNOSIS					CMKC

SEER

Acute Lymphoid Leukemia (ALL)

		

90.4%

87.2%

Acute Myeloid Leukemia (AML)

		

67.8%

62.3%

Hodgkin’s Lymphoma

			

97.6%

96.4%

Non Hodgkin’s Lymphoma

			

89.1%

86.5%

CNS (Central Nervous System)			

78.8%

73.2%

Wilms’ Tumor and other Non-epithelieal Renal Tumors

85.5%

89.7%

Neuroblastoma and Ganglioneuroblastoma		

85.4%

78.4%

Malignant Bone Tumors				61.6%

69.5%

Soft Tissue and Other Extraosseous Sarcomas		

61.9%

71.3%

Malignant Gonadal Germ Cell			

86.1%

95.7%

Five-Year Overall Survival - Patients Diagnosed from 2004 to 2013

Hodgkin’s Lymphoma (N=58, OS=98.0%)
Acute Lymphoid Leukemia (N=309, OS=89.7%)
Kidney Tumors (N=61, OS=88.9%)
Non-Hodgkin’s Lymphoma (N=60, OS=88.1%)
Neuroblastoma (N=93, OS=88.1%)
Central Nervous System Tumors (N=289, OS=77.0%)
Acute Myeloid Leukemia (N=90, OS=66.8%)
Bone Tumors (N=79, OS=61.0%)
Soft Tissue Sarcoma (N=75, OS=54.4%)

Frequency of Diagnosis 2013
Diagnosis
Central Nervous System
Astrocytoma
Glioma
Medulloblastoma
Ependymoma
Atypical Teratoid Rhabdoid
Gliobastoma Multiforme
Pineal Parenchymal Tumor
Gliomatosis cerebri
Germ Cell of CNS
Benign Borderline CNS
Leukemia
ALL
AML
Lymphoma
Non-Hodgkin’s
Hodgkin’s
Neuroblastoma
Bone Tumors
Osteosarcoma
Ewings
Kidney Tumors
Wilms’
Renal Cell Carcinoma
Langerhan’s Cell Histiocytosis
Germ Cell Tumor
Rhabdomyosarcoma
Retinoblastoma
Other Malignant
Myelodysplastic Snydrome
Hepatoblastoma
Malignant Rhaboid Tumor
Non- Rhabdo. Soft Tissue Sarcoma’s
Desmoplastic Small Round Cell
Infantile Fibrosarcoma
Synovial Sarcoma
Spindel Cell Sarcoma
Undifferentiated Round Cell
Carcinoma
Neuroendocrine Carcinoma
Papillary Carcinoma of Thyroid
Adenocarcinoma
Atypical Carcinoid
Benign Reportable Conditions
Teratoma
TMD/TAM- Transient
Myeloproliferative Disorder /
Transient Abnormal Myelopoiesis
Desmoid Tumors
TOTAL

Totals
54
10
12
3
3
3
5
1
1
3
13
39
32
7
13
7
6
10
9
3
6
3
2
1
7
7
5
3
13
1
1
1
5
1
1
1
1
1
5
2
1
1
1
11
7

2
2
174

Percentage
31

23

7

6
5

2

4
4
3
2
7

6

100
5

OVERVIEW

The Survive & Thrive Program offers comprehensive medical and
emotional care to childhood cancer survivors who are at least two
years off treatment and five years from the date of diagnosis.
The comprehensive care provided includes education on late
effects of cancer treatment and recommendations for maintaining
a healthy lifestyle. During a clinic visit, survivors are seen by an
oncologist, nurse practitioner, social worker and dietitian. The visit
includes a thorough physical exam and recommendations for
long-term follow-up care. A nutritional assessment, psychosocial
assessment and education are performed during visit based on
these recommendations. As survivors get older, preparation for
transition to adult providers is incorporated into each clinic visit.
Survivors are at risk for late effects from their cancer and treatment
at any point during or after therapy. Late effects of treatment
can be physical or emotional and typically appear in the second
decade of life. Some late effects resolve while others may become
chronic health problems. Late effects may be preventable or
modifiable, which is why yearly lifelong follow-up is important for
all survivors. The role of the Survive & Thrive Program is to ensure
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survivors and their families are aware of the potential late effects
and to assist with developing a long-term follow-up plan.
The team provides each survivor with a copy of their oncology
treatment summary, along with education about potential late
effects. A treatment summary is a document that summarizes a
survivor’s cancer history and includes: diagnosis, age at diagnosis,
dates on and off therapy, type of treatment received and doses,
surgeries, and any complications or known late effects. With this
information, a health care provider can begin to develop a followup plan to monitor survivors for late effects of therapy.
In the Survive & Thrive Program treatment summaries are
created using the Passport for Care® application. Passport
for Care is a secure electronic program developed by Baylor
College of Medicine and Texas Children’s Cancer Center.
Passport for Care links electronically to the Children’s Oncology
Group (COG) screening guidelines to assemble individualized
recommendations for follow-up that are based on a survivor’s
history. Passport for Care also offers educational resources which
help survivors better understand their potential late effects and

how to stay healthy. The team follows the COG Long-term Followup Guidelines for Survivors of Childhood, Adolescent and Young
Adult Cancers to develop an individualized follow-up plan for each
survivor.
Late effects are influenced by multiple factors including
diagnosis, treatment, gender, age at treatment, genetics and
lifestyle choices, to name a few. Due to the wide variation of late
effects, the Survive & Thrive team works closely with providers
in other specialties, including endocrinology, developmental
and behavioral sciences, cardiology, hearing and speech,
pulmonology and the liver care team. Through collaboration,
we have built relationships with providers who have an
understanding of how cancer therapy can impact a specific body
system. Our collaboration with endocrinology has led to having
an endocrinologist in the Survive & Thrive Program once a month

to see survivors. Combining clinics eliminates an appointment for
survivors and their families and allows providers to work together
to provide comprehensive care. Another benefit of the combined
clinic includes clear plans for transition of care, ensuring all
members of the medical team are sharing a clear and consistent
plan with survivors.
The graduation from treatment into the Survive & Thrive Program
is the beginning of the lifelong follow-up care that is crucial for all
childhood cancer survivors. Survive & Thrive ensures that survivors
receive the individualized care they need in a multidisciplinary
approach. The Survive & Thrive Program allows survivors to
see multiple providers in one visit focusing on maintaining and
improving health, along with screening for late effects of cancer
treatment.

Community Support for Survive & Thrive Program
Community support allows the Survive & Thrive Program an opportunity to provide more than just exceptional patient care. The support received
allows the team to provide the most up to date education materials to survivors, engage in research opportunities and develop educational
programs for community providers.

Lawrence Rock’n Bowl: The Lawrence (Kan.) Rock’n Bowl aims
to provide “a STRIKE in the fight against cancer.” With more
than two dozen kids from the Lawrence area being treated for
cancer at Children’s Mercy, the organizers of this annual bowling
tournament love hosting area families and supporters for an
afternoon at the bowling alley. Since 2013, the event has raised
more than $5,000 for Survive & Thrive with plans to continue to
grow its support.

County, Kan., Sunflowers to Roses
continues to raise the bar each
year, providing funds, awareness
and overall support for Survive &
Thrive.

Sunflowers to Roses Bike Ride: The annual Sunflowers to
Roses Bike Ride invites cyclists to “Join the fight. Enjoy the ride.”
Taking cyclists through the beautiful scenery of southern Johnson
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JEANETTA
DAVIS

Childhood is a time of fond memories for most people.
But, for Jeanetta Davis, it’s a time that—on a very basic
level—she simply endured.

“As a small child, I loved Children’s Mercy,” Jeanetta recalls. “All of
my nurses and doctors were so helpful and nice. They made the
whole experience a lot less scary. I still love going there.”

The 17-year-old’s earliest recollections center on chronic
pain that started around age 2. “My stomach constantly
hurt, and I was always throwing up,” she remembers.
“I’d be walking, and everything would get dark and then
disappear.”

Jeanetta says that, while the treatment she received at Children’s
Mercy saved her life, it was the people who truly impacted her.
“The personal connections and personal relationships I developed
with the staff helped me stay positive about my diagnosis,” she
explains. “There was always someone there to cheer me up or
accommodate me to the best of their ability.”

When her mother took her to the doctor for a check-up
at age 2½, he delivered a frightening diagnosis: stagefour neuroblastoma.

A Steadfast Source of Support

Since her diagnosis as a toddler, Jeanetta has been under the
care of the dedicated staff working in Children’s Mercy’s Oncology
Department. Treatments have included radiation, chemotherapy
and surgery. While many might consider the latter to be among
the memories a child might try to forget, for Jeanetta, her
surgeries were a fortunate aspect of her experience.

By age six, Jeanetta was no longer in her mother’s care.
Over the next 10 years, she moved through a series
of foster homes. But while the individuals overseeing
her day-to-day care rotated in and out of her life,
one constant stood firm and welcoming: the staff at
Children’s Mercy Hospital.

“My doctors always made sure I had whatever toys I wanted
before my surgeries,” she says with fondness. “They picked out
movies for me to watch to get me in a good mood. Afterward,
they pampered me with snacks and Sprite. I loved that I got to
rest peacefully after each of my surgeries or a day of tests. I was
always so tired.”

It was only the beginning of Jeanetta’s dark childhood
memories.
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A Future Focused on Others
Today, Jeanetta lives in Kansas City, Kan., with foster parents
LeeAnn and Mike French. Jeanetta arrived at her current home on
her 16th birthday, and no gift could have been sweeter to a young
woman who had endured so much.
“She’s been a huge blessing in my life,” Jeanetta says of LeeAnn,
“not just regarding taking care of my medical needs but as an
overall parent. She’s always taking me to my appointments and
trying to keep me well.”
That loving care has been important because, while she’s been
in remission since she was 5, Jeanetta’s health has never been
like other children’s. “I couldn’t always play and run around like
the other little kids,” she explains. “I’ve always had many doctor’s
appointments and check-ups to deal with. Since middle school,
my health has been better. But I get severe sinus infections
because my immune system is compromised and very weak.”
Jeanetta’s cancer also caused her to develop hypothyroidism, a
health concern she’ll have to manage for the rest of her life.
Such issues are common among child survivors of cancer, who
can face a variety of health issues as they mature. Referred to as
late effects, such issues often don’t show up for two to five years
after treatment—and often even later.

Helping Survivors Thrive
To support children like Jeanetta,
who just turned 18 in December,
Children’s Mercy created the Survive
& Thrive Program. The program
helps childhood cancer survivors and
their families understand the potential
late effects that can occur. It also
ensures necessary screenings continue
over the ensuing years and helps with
the transition of medical care to adult
providers.
“By utilizing a treatment summary,
we can make sure Jeanetta

receives all the recommended screenings to detect late effects
early, such as echocardiograms to detect heart dysfunction,” says
Joy M. Fulbright, MD, Director of the Survive & Thrive Program.
“We’ll provide Jeanetta with the education she needs to be aware
of changes in her body to bring to the attention of a health care
worker.”
Dr. Fulbright says the program will also empower Jeanetta to lead
a healthy lifestyle by providing nutritional support—another key to
helping the young woman remain healthy in years to come.
Jeanetta says such forward-thinking care is just another example
of what makes Children’s Mercy so commendable. “Children’s
Mercy definitely is a technologically advanced hospital and is one
of the best
hospitals for
children with
cancer,” she
says.
That care was
so impactful
that it has
influenced
Jeanetta’s
career plans.
“From the
positive
experiences
I had at the
hospital,”
she explains,
“I knew I
wanted to help others and return the favor.” Thus, she’s set her
sights on being an attorney so she can aid other children in foster
care.
LeeAnn hopes others recognize what a caring place Children’s
Mercy is. She says, “They really make you feel everything will be
ok.”
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SECONDARY
MALIGNANICES

Alan Gamis, MD

Many cancer survivors are at an increased risk of developing
another cancer because of the therapy they received to treat their
primary cancer. Cancers that develop due to cancer treatment are
classified as secondary malignancies (SMNs).
The treatment for most types of cancer includes radiation therapy
and/or chemotherapy. Traditional chemotherapy targets fastgrowing cells by interrupting the process of cell/division and
growth. It does this by interfering with the copying of DNA.
Unfortunately, cancer cells are not the only cells in the body
which are growing fast, so damage to the DNA of healthy cells
also can occur. Radiation targets the DNA of the cells in the area
of the radiation field. This DNA damage places patients at risk
for developing another cancer. Patients with specific genetic
mutations may be at an even higher risk of developing a SMN or
another primary malignancy.
The type of SMN a patient is at risk for depends on many factors,
including the dose and type of chemotherapy, dose and location
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of radiation therapy, underlying genetics, and environmental
exposures. Having a treatment summary is essential in helping
determine the risks a cancer survivor has for developing a SMN.
In our Survive & Thrive Program, we review a patient’s treatment
summary and discuss a patient’s risk factors for developing a
SMN. We monitor patients for these SMNs and also give guidance
to the patients and their families regarding signs and symptoms
of a secondary cancer.
The incidence and type of SMNs diagnosed between Jan. 1, 1995
and Dec. 31, 2013 in patients previously treated for cancer at
Children’s Mercy are listed in Table 1. Incidence of SMNs in our
patient population during this time period was 1.4 percent. The
Childhood Cancer Survivor Study (CCSS) is a study of a cohort of
patients that were diagnosed with primary cancer under age 21
between Jan. 1, 1970 and Dec. 31, 1986, and survived at least five
years after initial diagnosis. The CCSS reported incidence of 3.2
percent of SMNs (excluding non-melanoma skin cancers-NMSCs)
when they evaluated this cohort in 2000.1

The CCSS continued to follow the same cohort of patients and
as of Jan. 1, 2006 reported a cumulative incidence of SMNs
increased to 9.3 percent. This emphasizes the importance of
patients being followed long-term for the risk of developing SMNs.
In the Children’s Mercy cohort the most commonly reported SMN
was leukemia where in the CCSS cohort leukemia is the sixth
most common diagnosis. Breast cancer and thyroid cancer are
the two most common. The difference in secondary malignancy
types and incidence is likely due to the time from therapy patients
were followed and change in therapy from the time from the
CCSS patients were treated to when our patients were treated.
The majority of the patients in the Children’s Mercy cohort were
diagnosed with primary cancer after 1990.
A major emphasis in the Survive & Thrive Program is prevention of
SMNs. Skin cancer is one of the secondary malignancies that we
can help reduce the risk of developing. We review the importance
of sun safety and distribute age-appropriate literature that reviews
what changes in a mole are concerning, how to perform self-skin
checks and sun safety at patient’s yearly visits. Importance of
avoidance of tobacco products is discussed starting at a young
age.
Another part of prevention is performing and obtaining screening
exams per national recommendations. For some of our patients,
these exams need to occur earlier than the general population
due to their cancer therapy. For example, females who have
received chest radiation may need to receive breast exams as
early as age 25 due to their increased risk for breast cancer.
Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in
survivors of childhood cancer: findings from the Childhood Cancer
Survivor Study cohort. J Clin Oncol. May 10 2009;27(14):2356-2362.
1.

Children’s Mercy
Secondary Malignancies
Definition: A second malignancy, also known as a
subsequent primary, is any distinct cancer diagnosed
after the first one and not related to it. A patient
with more than one primary is said to have multiple
primaries.
Total Patients with Malignancies
Diagnosed - 1995-2013 = 2,154
SECONDARY MALIGNANCIES – 31 – 1.4%

Table 1
SECONDARY
MALIGNANCY

NUMBER

PERCENT

Myeloid Leukemia

8

25.8

Osteosarcoma

6

19.4

CNS

4

13.0

Myelodysplastic Syndrome

4

13.0

Lymphoma

2

6.4

Melanoma

2

6.4

Thyroid Carcinoma

2

6.4

Gastrointestinal Stromal Tumor (GIST)

1

3.2

Peripheral Nerve Sheath Tumor

1

3.2

Renal Cell Carcinoma

1

3.2
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CARDIOLOGY

Monitoring cardiac health is critical during and after treatment
for cancer. Before chemotherapy or stem cell transplant, an
electrocardiogram and echocardiogram are routinely performed
for baseline cardiac health assessment. Sometimes, there is
decline in cardiac function in the initial stages of cancer treatment.
A cardiologist can work with the oncologist to improve/stabilize or
prevent further decline in cardiac function in these children. More
commonly, there is a slow decline in cardiac function over years
or decades after cancer treatment. Thanks to previous long-term
studies, we know that about 15 percent of kids will develop heart
failure over a period of 30 years. Additionally, 10 percent of them
will develop strokes in that time period. The latest, 2013 guidelines
of the Children’s Oncology Group recommends echocardiogram
surveillance of cardiac function every one, two or five years
depending on the nature and intensity of the cancer treatment
and likelihood of cardiac dysfunction.
Cardiology also works closely with the Survive & Thrive Program to
monitor for late effects of cancer therapy and promotes a healthy
lifestyle to prevent development of late effects. Depending on the
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findings on the surveillance echocardiogram, we recommend a
clinical evaluation and medical management. We are working on
newer and more advanced methods like 3-D echocardiography,
cardiac MRI and cardiac biomarker testing for precise detection
of cardiac dysfunction or cardiac health for cancer survivors. We
routinely participate in local community events aimed at improving
education and awareness about cardiovascular health, either
directly in face-to-face meetings or also using webinars for a
much broader audience. Our future endeavors will be aimed at
improving and maintaining cardiovascular fitness and endurance
of cancer survivors. We are thankful for charitable foundations like
Tom Keaveny Foundation for cancer research to improve cardiac
care of cancer survivors through generous research funding. Most
importantly, we are routinely inspired by the amazing resilience
and character of our pediatric cancer survivors.

Pediatric audiologists are active members of the
multidisciplinary team caring for Survive & Thrive
patients. Pediatric audiologists hold doctorate
and/or master’s degrees in hearing process
and pathology and are nationally certified
through the American Speech-Language
Association. Our nineteen pediatric audiologists
at six sites use various behavioral and
electrophysiologic test procedures to monitor
hearing acuity, evaluate changes in hearing
sensitivity, and provide hearing aid services as
needed.

to continue to see these cancer survivors after
completion of treatment through their twentyfirst birthday.

Some of the young people seen in Survive &
Thrive already have experienced hearing loss
secondary to radiation and/or chemotherapies.
Hearing loss in this population typically begins
in high frequencies affecting understanding
of speech
especially in
the presence
of background
noise. Some
survivors
already are
hearing aid
users and
some may
become
hearing aid
users over
time. The
audiologist’s role is to assess hearing and
address any changes in hearing sensitivity over
time. Speech understanding measures are also
used to determine how the loss is affecting
the patients understanding and the need for
amplification to assist these patients. With the
Survive & Thrive Program, audiologists are able

Education is a major role for the audiologists
with these patients. Patients who have
undergone chemotherapy may experience
worsening of an already present loss and/or
delayed onset hearing loss secondary to their
past treatments. Additionally, like the rest of
us, their hearing will also be affected by the
aging process and exposure to toxic agents in
the environment, including noise. Aging and
noise have an additive effect on an already
present hearing loss. Hearing conservation is
of the utmost importance. Audiologists counsel
patients about the importance of hearing
health, listening to music at appropriate
volumes, decreasing amount of time listening to
loud music, and wearing ear protection in noisy
environments are among the topics discussed.

When patients become candidates for
amplification, the audiologist provides them with
a ‘hands on’ opportunity to explore amplification
solutions that will work best for them in their
own unique situation. During this consultation,
patients and families learn more about their
hearing loss and the benefits and limitations of
different types of aids.

HEARING &
SPEECH

As these young adults approach age 21, the
audiologist works with patients and families on
transition of care assisting them in finding adult
audiology services in their communities. It is a
great feeling to see these patients ‘survive and
thrive’ and go out into our community as young
adults.
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TONY
MANCILLA

As he began developing health issues as a child, Tony Mancilla
learned to become very resourceful.
“I was about 8 years old, or 9, when my
eyesight started going bad,” he says. “I
noticed I wasn’t seeing as well as I used to.
And, then, it got really hard for me to know
where I was going and to see who was
who.”
Not one to let his deteriorating eye sight
interfere with his life, Tony learned how to
accommodate his growing disability. “Once
I recognized voices,” he matter-of-factly
explains, “I knew who I was talking to.”
Diagnosed with neurofibromatosis, a
genetic disorder of the nervous system,
Tony was treated with radiation under the
guidance of Children’s Mercy Hospital to
eliminate the tumors that were pressing
on his optic nerve and causing his blindness. That treatment
eventually gave him back some of his vision. In the meantime, the
Kansas City, Kan., resident developed additional techniques to
help him identify those around him.
14

“I created a method of knowing who was who. It was either by the
scent of their skin or the perfume or cologne they were wearing,”
he says. “That’s what I would use to determine who was who even
before they would speak to me.”
In the early years of Tony’s treatment, his health journey was
managed by the pediatric medical experts at Children’s Mercy
Hospital. As he matured, he transitioned to the hospital’s Survive &
Thrive Program.
“I am so happy and very grateful that Children’s Mercy Hospital
exists,” Tony says. “If it weren’t for their help, I would not be the
person I am today, and I am very appreciative of that.”
Last March, Tony turned 21, a milestone in his care journey. As an
adult, he was ready for a new support network – one that would
further encourage the resourcefulness he exhibited as a boy: the
University of Kansas Cancer Center Survivorship Transition Clinic,
a joint effort with Children’s Mercy and the Midwest Cancer
Alliance.
Kyla Alsman, RN, BSN, a “nurse navigator” at the clinic, says
the program provides Tony with a contact person to help him
navigate his way through the adult hospital setting. “Transition is
very hard for individuals,” she explains, “especially ones who have
a significant health history like Tony.”

Becky Lowry, MD, Tony’s new primary care physician at the clinic,
says such individuals are particularly in need of monitoring and
education about the previously mentioned late effects—conditions
related to their prior illness and treatment that can manifest years
later. The clinic helps with this care by developing a plan that is
specific to each individual patient’s history.
“While guidelines exist for late effects monitoring,” she says, “they
are 200 pages long and require a thorough treatment summary
for providers to utilize them correctly. We know from the literature
that most internal-medicine physicians prefer treating patients
like Tony in collaboration with a survivorship/long-term follow-up
clinic. Our survivorship clinic provides this focused late-effects
monitoring and education for patients like Tony.”

Tony and his
mom, Delia

The clinic provides an adult setting that assists with navigating
further subspecialty care that patients may require in adulthood.
“Nationally, most survivorship clinics for patients with a history of
childhood cancer are based out of children’s hospitals or pediatric
clinics,” Dr. Lowry explains. “Ours is one of a handful of adultbased survivorship clinics dedicated to these patients. We are so
fortunate to have providers who are dedicated to the collaboration
efforts between Children’s Mercy and the University of Kansas
Medical Center, as this is such an important service for patients.
“Pediatric providers and adult providers do not necessarily
interface regularly. So, when patients graduate from
pediatric care and inquire about adult primary and
subspecialty providers, it can be difficult for pediatric
physicians to guide them,” she adds.
Dr. Lowry says that the biggest challenge for
new patients is simply anticipating the first
appointment. “Some patients describe anxiety
even when seeing one of their primary doctor’s
partners for urgent-care visits, such as a sinus
infection,” she says. “As you can imagine,
making a move from a pediatric facility and
team of providers who has cared for you during
what was likely a very stressful time in your life

to a new adult facility and new team of providers can be, frankly,
frightening.” Dr. Lowry, then, says it’s been rewarding to see
patients’ relief when they realize their new care team is already
familiar with their history and follow-up needs.
“Now that I’m going to the KU Hospital,” Tony explains, “it’s a
new step for me in my life, because I have to be reliable and
responsible for my own appointments.”
He adds, “I like the hospital, because they are helping me out—
because they are making sure that I’m okay.
“At the time when I was at Children’s Mercy Hospital,” he adds, “I
enjoyed it and appreciated the help that was given to me. I feel
so lucky and so blessed to have received their help, and I am very
thankful.”
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ENDOCRINOLOGY

Sripriya Raman, MD

It is estimated that about one in every 640 young adults
living in the United States is a childhood cancer survivor.
Studies show that 40 percent of all childhood cancer
survivors will have one or more endocrine disorders in their
lifetime. Endocrine late effects from prior cancer treatments
(growth hormone deficiency, thyroid, gonadal or adrenal
dysfunction, obesity, poor bone health) are among
the most common complications in childhood cancer
survivors. Patients exposed to high doses of alkylating
agents and radiation therapy are particularly at high risk
for developing endocrinopathies (e.g. survivors of CNS
tumors, hematopoietic stem cell transplant and Hodgkin’s
lymphoma).
The Endocrine Disorders In Cancer Survivors (EDICS) Clinic
focuses on providing comprehensive endocrine care to the
cancer survivors referred from Survive & Thrive Program
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and other oncology services. In addition to receiving
hormone replacement therapy, patients are educated
on their medical condition and possible future endocrine
problems based on their individual cancer treatements.
EDICS team providers are Julia Broussard, MD, and Sripriya
Raman, MD. EDICS Clinic makes Children’s Mercy one of
the few places in the country with a subspecialty clinic
focused on endocrinopathies in childhood cancer survivors.
The EDICS Clinic team works closely with the Survive
& Thrive team to coordinate patients’ medical care,
accommodate survivors’ needs and make it easier for
them to attend Children’s Mercy appointments. That is
why the Endocrine and Survive & Thrive (EaST) Clinic was
created. EaST Clinic is a monthy multidisciplinary clinic.
During this clinic, patients and their families are seen
by oncology, endocrine, nutrition and social work, with

laboratory/imaging services coordinated to take place on the
same day. This collaboration leads to a decrease in time away
from school/work for patients and their families and enhances the
clinical and research opportunities for both teams.
October 2013 marked the beginning of the quarterly EDICS
Transition Clinic. Also, in order to improve access to our services
for patients who live far away, the EDICS Telemedicine Clinic will
start in July 2014 in St. Joseph, Mo. and expanded its services to
Joplin, Mo.
The successful collaboration between the EDICS and Survive &
Thrive team has resulted in improved patient care and increased
family satisfaction with the medical care at Children’s Mercy.

Julia Broussard, MD
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SOCIAL
WORK

Amanda Trout, MSW, LCSW

During a visit to the Survive & Thrive Program, the social worker
completes a yearly comprehensive psychosocial assessment of
each patient and family as recommended by the COG Long-Term
Follow-up Guidelines.
While many pediatric cancer survivors adjust well throughout life,
some experience psychosocial
late effects from treatment.
Cancer treatments can affect
educational progress during
treatment due to absences and
low energy levels. Additionally,
some treatments that target the
central nervous system (brain
and/or spinal cord) may affect
memory and learning abilities,
which can affect educational or
vocational progress long term.
Pediatric cancer survivors can
also struggle with emotional
issues, such as anxiety,
depression, post-traumatic
18

stress, and social withdrawal. Financial stressors, such as access
to health insurance, may also be present. For adolescent and
young adult pediatric cancer survivors, transition to adult care can
be particularly stressful. A social worker can assist with identifying
and addressing barriers related to transition and provide support
through this process.
Based on risk factors identified
during the assessment
process, patients and families
are provided with referrals
to appropriate professionals
or community agencies for
further evaluation and support
services. Supportive counseling
can also be provided during the
clinic appointment itself, and
the social worker is available
as needed to provide ongoing
psychosocial support.

The Children’s Mercy Survive & Thrive Program
is a multidisciplinary team that serves pediatric
survivors of cancer. Our goal is to evaluate and
monitor patients for potential developmental
late effects that can result from cancer
treatments. Based on presenting needs or
concerns, referrals are made to appropriate
specialists. The role of a clinical psychologist
within the Survive & Thrive Program, is available
for both individual and family therapy services
and neuropsychological testing for cancer
survivors.
It is not uncommon for patients to experience
lingering physical, psychological and
interpersonal challenges. While many cancer
survivors adapt in overall healthy ways, many
struggle with symptoms of depression, anxiety
and post-traumatic stress. Many patients may
also experience worry, guilt, concerns about
body image, communication difficulties with
family members and peers, feelings of losing
control, sadness and confusion or fear about
recurrence that cause significant distress or
disruption to their daily lives. For these patients,
individual cognitive-behavioral therapy can be
effective. This psychological intervention focuses
on identifying and correcting dysfunctional
thoughts and incorporates relaxation
techniques and problem-solving skills, a
combination that works to reduce distress and
improve adjustment.

& Thrive provides annual evaluations for cancer
survivors which allow us to monitor changes,
identify any new concerns and connect patients
with the appropriate resources and services.
When needed, some patients may be referred
for neuropsychological testing, which involves a
variety of activities that allow us to observe how
a child or adolescent processes and responds
to different kinds of information. Based on the
results of this detailed testing, families are
provided with (1) an understanding of how
treatment has affected thinking, learning and
behavior, (2) a picture of the patient’s strengths
and weaknesses, (3) identification of what
services and accommodations may be needed
in the educational or vocational setting and (4)
any necessary referrals for cognitive behavioral
therapy.

PSYCHOLOGY

Lisa Peters, LMSW, LCSW

It is estimated that about 40 percent of
pediatric and adult cancer survivors experience
impairments in their cognitive abilities (e.g.,
difficulties with attention and concentration,
short-term memory, processing and organizing
complex information). Because of this, Survive
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EMILY
CONNOR

When intense stomachaches made 21-month-old Emily Connor of
Liberty, Mo., unusually lethargic and weak, her parents, Scott and
Denise Connor, were told not to worry. She had the flu.

doctors and said, ‘We have five other children and we aren’t overly
paranoid parents. We truly believe something is seriously wrong.
Please figure something else out, because we aren’t leaving.’”

But after 14 days of doctor visits, antibiotics and no improvement,
Emily was taken to the Emergency Department
at Children’s Mercy Hospital.

Emily underwent a CT scan. The test results would change Emily’s
and the family’s lives forever.

“Emily was outgoing from the day she was
born,” Denise said. “But we noticed she was
acting very different—quiet and upset. We
knew something was wrong.”

Discovering the Problem
Initially, the doctors at Children’s Mercy
believed Emily likely had a stomach virus.
Parental instinct made Scott and Denise insist
that something else be considered.
“At this point, we knew whatever was wrong
had to be serious because when she tried to
smile, half of her mouth drooped just a little
bit. It was almost unnoticeable, but it was
there,” Scott recalled. “So, we looked at the
20

Receiving the News
“I just remember a brigade of people in white coats coming into
the room to give us an update,” said Denise. “We knew as soon
as they opened the doors and we saw all those people that it
probably wasn’t good news.”
On March 17, 2002, exactly 21 months from the day of Emily’s
birth, the Connor family was faced with devastating news: Emily
had brain cancer.
“Emily had an Atypical Teratoid / Rhabdoid Tumor (ATRT) of the
brain that was more than seven centimeters in diameter and
had wrapped itself around a major artery,” describes Maxine
Hetherington, MD, the pediatric oncologist who oversaw her care.
“ATRTs are very rare, high-grade tumors that occur most often in
children under the age of 3.”

ATRTs are also extremely aggressive,
making the survival rate for children
diagnosed before the age of 3 less
than 10 percent. Being only 21 months
old, Emily’s situation seemed grim.

Treatment
A few days later, Emily underwent
surgery with Gregory Hornig, MD,
Neurosurgery Section Chief at
Children’s Mercy. After a five-hour
operation, more than 90 percent of the
tumor was removed.

Emily with dad Scott

Following surgery, Emily received six
rounds of chemotherapy. The latter half
of her chemotherapy treatments were combined with a procedure
called stem cell rescue. This allows stem cells to be taken from
Emily’s body and then put back immediately following these highdose chemotherapy sessions. In the fall of 2002, Emily underwent
six weeks of intensity-modified radiation therapy to try and kill any
remaining tumor.
Just when the Connor family thought they were
through the treatment process, an MRI in early
2003 showed the tumor had returned. Having
exhausted their chemotherapy options, Emily
underwent gamma knife surgery, again with Dr.
Hornig, to irradiate the tumor bed. Shortly after, she
began blood brain barrier disruption” treatments
monthly until February 2004. In June of that year,
Emily received an “all clear” MRI that would put
her on the road to being cancer-free. Regular
checkups with the team at Children’s Mercy
continue to this day.

Ten Years Strong
Now 14, Emily is as gregarious and lively
as ever. She is a patient of the Children’s

Mercy Survive & Thrive Program, which provides specialized
services for cancer survivors. Emily’s parents, who never let Emily
stay in the hospital without one of them present, say Emily has
always been a fighter. Despite a number of side effects from her
prior cancer and treatments, Scott says she has the most positive
outlook on life of anyone he knows.
“She is an inspiration to everyone who meets her,” says Scott.
“Effects of childhood cancer can develop as late as 10 years after
treatment, sometimes more,” said Wendy McClellan, RN, MSN,
CPNP, Survive & Thrive. “Our goal is to make sure survivors and
their families get the proper medical and emotional care they
need for these sorts of problems.”
Summer, 2014 marked the 10-year anniversary that Emily has
been cancer-free.
“In some ways it seems like a lifetime ago, and in others it seems
like yesterday,” said Denise. “You don’t realize how special a
place like Children’s Mercy is until your family needs it. We are
truly blessed to have an institution like this in our community. We
can never repay the gift that Emily received from Dr. Hetherington,
Dr. Gilman, Dr. Hornig, all of her nurses, and the entire staff that
continues to oversee her treatment and recovery.”
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NUTRITION

Sara Jehle, MS, RD, LD

Dietitians perform many roles in the Survive & Thrive Program at
Children’s Mercy. Patients and families meet one-on-one with a
dietitian at their annual Survive & Thrive visit to discuss current
dietary habits.
Education is provided to each patient in an effort to help them
develop healthy habits to help reduce the risk of chronic disease
development. Dietitians also aid in monitoring the potential side
effects from chemotherapy, radiation and/or surgery treatments.
Potential side effects from treatment that can be influenced by
nutrition include growth (weight and height), fat levels in the blood
and bone health.
Patients’ diets are assessed by the dietitian for nutritional
adequacy by discussing what the patient typically eats in a day.
Areas of nutritional success and areas where improvement could
be warranted are identified. These areas are used as the basis
for nutrition goals. Fruits, vegetables, whole grains and calcium
intake, along with physical activity guidelines, are examples of
healthy lifestyle education provided to patients frequently.
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Growth charts are actively monitored to ensure the patient is not
gaining too little or too much weight and also show adequate
growth in height. If a patient experiences inadequate weight
gain, supplements are often recommended. Dietitians also work
with these patients to help them identify high-calorie foods that

are nutrient dense (i.e. whole-fat dairy, avocados) and can add
to their daily intake to promote weight gain. If excess weight
gain is experienced, weight management techniques are used
focusing on strategies to decrease the intake of sugar-sweetened
beverages, decrease the frequency of high-calorie meals/snacks
and increase physical activity. Dietitians also assist the medical
team in identifying patients who may not be reaching their height
potential and discuss with the team if a referral to endocrinology
for a growth hormone evaluation would be beneficial.
Blood fat levels such as triglycerides and cholesterol may be
elevated in some of the Survive & Thrive patients. Dietitians play
a role in monitoring these lab results, providing education to the
family on dietary management of elevated levels. For example,
triglyceride levels may be lowered by decreasing sugar and fat
intake and by weight loss. Bone health can also be compromised
in these patients. Dietitians assess calcium and vitamin D intake at
each clinic visit. Patients learn about their calcium and vitamin D
needs, foods high in calcium and vitamin D and over-the-counter
supplements available if intake from food sources is inadequate.
The Survive & Thrive dietitian follows the patients on an annual
basis. Additional in-person meetings or telephone calls are also
available in an effort to keep the patient on track for a healthy
lifestyle.

The need for long-term follow-up care of
childhood cancer survivors has been well
established and guidelines now exist to help
providers monitor for late effects of treatment.
However, there continues to be a knowledge
gap among health care providers in several
topics related to monitoring and early diagnosis
of long-term effects. To fill the gap in Fall 2013,
we implemented a project titled “Bridging the
Gap - Caring for the Adolescent and Adult
Survivors of Childhood Cancer.” Funding was
obtained through the Midwest Cancer Alliance.
The goals of this project were to assess health
care providers’ knowledge of the unique
needs of childhood cancer survivors; develop
a face-to-face meeting and web-based
educational series to improve that knowledge;
and evaluate performance improvement
strategies among selected clinical sites. We
recruited local, regional and national leaders
with experience, talent and a vested interest in
provider education and patient management of
childhood cancer survivors to lead this project.
A one-day regional educational conference
was conducted and attended by 35 physicians,
nurses, advanced practice nurses, social
workers and allied health professionals. This
conference was designed to provide the most
current information regarding late effects of
treatment and use of the latest COG survivor
guidelines. In addition, the workshops provided
a forum for networking between primary care
providers and subspecialists. We conducted
a survey of participants that demonstrated an

overall improvement from the pre-conference
survey results to the post-conference survey
results. The keynote speaker was Tim Folse, MD,
who is the Clinical Director for The St. Jude LIFE &
After Completion of Therapy Clinics.

BRIDGING
THE GAP

In 2014, we are into Phase 2 of the Bridging the
Gap project, conducting ongoing webinars. Web
conferences are clustered into four sessions
focusing on the most common late effects of
cancer therapy – endocrine, fertility, cardiac
and psychosocial issues. Each session includes
topics that cover guidelines for screening and
provide reliable, readily obtainable resources
that can be used in
clinical practice.
Webinar sessions
focus on educating
health care providers
on the late-effects
of cancer therapy,
current COG
guidelines for
screening, expert
recommendations on
how to utilize history
and clinical exam to
diagnose problems
early, and appropriate
referral patterns.
The program also provides an opportunity for
participants to meet the local experts and build
a support network for clinical advice when
needed.

23

TRANSITION

Kyla Alsman, RN, BSN

Transition of care is a gradual process. Preparation begins
years before a survivor reaches 21 years of age. In the Survive &
Thrive Program, transition is first introduced around 12 years of
age and incorporated into each clinic visit until a survivor leaves
Children’s Mercy. Transition preparation requires more than just
establishing care with adult providers. Many survivors were very
young when they were treated or may not recall details of their
treatment.
In the Survive & Thrive Program, survivors are encouraged to
learn about their history and be able to share their history with
medical providers. A developmentally appropriate transition
readiness screening tool is used to facilitate a conversation
with survivors during clinic visits. This tool allows the team
to assess a survivor’s knowledge of their medical history,
current problems, risks and progress toward transition. The
transition readiness screener is first introduced when planning
for transition of care first begins. The goal is for survivors to
feel comfortable discussing their history and risks with future
health care providers and encourage independence. Transition
is an individualized process that may occur at different times
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for each survivor. Along with the transition readiness screener,
a three-sentence summary is utilized to guide survivors in
communicating their medical history in a concise manner.
Transition preparation promotes autonomy, responsibility and
self-reliance. Our goal is to empower our survivors to take
charge of their health so they can advocate for themselves as
they transition to the adult world.

University of Kansas Cancer Center Survivorship
Transition Clinic
A long-term collaboration with Midwest Cancer Alliance (MCA),
the outreach arm of The University of Kansas Cancer Center
(KUCC), and Children’s Mercy has resulted in the launch of the
Survivorship Transition Clinic at the University of Kansas Medical
Center. The Survivorship Transition Clinic is one of the few clinics
in the nation that represents collaboration between a freestanding children’s hospital and an adult hospital. The clinic is
designed to meet the ongoing and unique health care needs of
adolescent and young adult survivors who are ready to transition
to an adult setting.

MCA is a membership-based organization bringing cancer
research, clinical and support professionals together to advance
the quality and reach of cancer prevention, early detection, care
and survivorship programs across Kansas and western Missouri.
MCA connects The University of Kansas Cancer Center with
the physicians, nurses and patients battling cancer throughout
the region and provide access to cutting-edge clinical trials for
patients as close to home as possible. The
MCA organization includes the Partners
Advisory Board and the Clinical Trials
Network.
The MCA Partners Advisory Board
is a partnership among KUCC and
major regional hospitals and research
institutions. The purpose of the
board is to maintain National Cancer
Institute designation and advance
the pursuit of Comprehensive Cancer
Center designation for the region by
demonstrating collaboration in the areas
of research and education and providing
annual financial support.

Community Support for KUCC
Survivorship Transition Clinic
Tour de BBQ Bike Ride:
Known as the best-tasting cycling event
around, the Tour de BBQ Bike Ride does more
than just fill cyclists’ bellies with good BBQ.
Since 2012, this popular event has raised more
than $150,000 to support a nurse navigator
position for the Survivorship Transition Clinic,
which helps survivors transition successfully
from pediatric to adult care.
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TRANSITION

The collaboration between MCA, KUCC and Children’s Mercy
allows the transition to be seamless as we address challenges
and support the survivors. However, transition of care is not
without challenges.
For survivors, leaving
the familiarity of the
pediatric setting can
feel overwhelming.
Survivors want to
know their providers
are familiar with
their history and
future risks. For
adult health care
providers unfamiliar
with pediatric
oncology, there is
a knowledge gap
regarding the needs
of survivors and the
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health risks they face. A nurse navigator works jointly with the
Survive & Thrive Program and the Survivorship Transition Clinic
at the University of Kansas Medical Center (KUMC). Survivors
become acquainted with the nurse navigator prior to leaving
the Survive & Thrive Program. The nurse navigator is available
to assist survivors as they navigate a new health care system.
The Survivorship Transition Clinic allows survivors to see a health
care provider who is familiar with the COG survivor guidelines,
as well as the unique needs of this population. The collaboration
between the Survive & Thrive Program and the Survivorship
Transition Clinic allows the nurse navigator and the physician to
have additional support when caring for survivors.
The Survivorship Transition Clinic includes a review of the
patient’s history and treatment, a comprehensive physical,
and a psychosocial evaluation. Similar to the Survive & Thrive
team, the Survivorship Transition Clinic staff collaborates with
multiple specialties to meet the variety of needs of these
survivors and make referrals to specialists when necessary.
The nurse navigator educates survivors about the most recent
recommendations for ongoing follow-up and healthy lifestyle

choices. The goal is to inspire survivors to take charge of their
health care in order to minimize their risks.
The collaboration with MCA will increase opportunities to
transition survivors to health care providers in their own
community. Through MCA, the Survive & Thrive Program team
and Survivorship Transition Clinic team will have increased
opportunities to provide support, education and resources to
providers caring for survivors around the Kansas City metro
area and across the state of Kansas. MCA’s collaborations
with health care providers across the Heartland provide
the opportunity in the future to incorporate telemedicine
into the Survivorship Transition Clinic. Telemedicine would
allow survivors who live miles away to receive the same
benefits and care of the Survivorship Transition Clinic in more
locations, closer to home and increasing the opportunities
to collaborate with health care providers in the communities
where survivors live.
Having the Survivorship Transition Clinic at KUMC gives
survivors an opportunity to continue to receive care
in an environment modeled after the Survive &
Thrive Program. The collaboration between
Children’s Mercy, MCA and KUMC
will provide more opportunities
for networking, education
and research, which are all
essential components in
ensuring survivors receive
the care they need.
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